NO20090163L - Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans - Google Patents

Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans

Info

Publication number
NO20090163L
NO20090163L NO20090163A NO20090163A NO20090163L NO 20090163 L NO20090163 L NO 20090163L NO 20090163 A NO20090163 A NO 20090163A NO 20090163 A NO20090163 A NO 20090163A NO 20090163 L NO20090163 L NO 20090163L
Authority
NO
Norway
Prior art keywords
active substance
poorly water
soluble active
preparations including
combination preparations
Prior art date
Application number
NO20090163A
Other languages
English (en)
Inventor
Henricus R M Gorissen
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20090163L publication Critical patent/NO20090163L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen er relatert til en oral sammensetning av benzazepin-1-eddiksyrederivater omfattende a) nevnte aktive forbindelse i en mengde på mellom I 0 og 65 % av den totale vekten av formuleringen; b) minst 10 vekt-% av en alkalisk forbindelse eller en blanding av alkaliske forbindelser; c) omfatter eventuelt hjelpematerialer i en mengde på mellom I% og 45 % av den totale vekten av formuleringen. Oppfinnelsen er videre relatert til den ovenfor definerte orale sammensetningen omfattende natriumkarbonat med en spesifikk partikkelstørrelse og/eller overflateareal som alkalisk forbindelse.
NO20090163A 2006-06-16 2009-01-12 Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans NO20090163L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81407606P 2006-06-16 2006-06-16
EP06115582 2006-06-16
PCT/EP2007/055937 WO2007144418A1 (en) 2006-06-16 2007-06-15 Oral pharmaceutical composition of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
NO20090163L true NO20090163L (no) 2009-01-14

Family

ID=38475902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090163A NO20090163L (no) 2006-06-16 2009-01-12 Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans

Country Status (10)

Country Link
EP (1) EP2034967B1 (no)
JP (1) JP2009539940A (no)
KR (1) KR20090032085A (no)
AT (1) ATE509620T1 (no)
AU (1) AU2007259252A1 (no)
CA (1) CA2654111A1 (no)
EA (1) EA014898B1 (no)
IL (1) IL195531A0 (no)
NO (1) NO20090163L (no)
WO (1) WO2007144418A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2788289B1 (de) * 2011-12-09 2019-07-31 Merck Patent GmbH Porenarmes, wasserfreies natriumcarbonat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

Also Published As

Publication number Publication date
WO2007144418A1 (en) 2007-12-21
EP2034967A1 (en) 2009-03-18
CA2654111A1 (en) 2007-12-21
KR20090032085A (ko) 2009-03-31
EA014898B1 (ru) 2011-02-28
EP2034967B1 (en) 2011-05-18
IL195531A0 (en) 2009-09-01
EA200970020A1 (ru) 2009-06-30
AU2007259252A1 (en) 2007-12-21
JP2009539940A (ja) 2009-11-19
ATE509620T1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
ATE219659T1 (de) Verwendung gelierbarer pharmazeutischer zusammensetzungen in der parodontologie
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
AR061134A1 (es) Derivados de tioxantina
CR9626A (es) Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
NO20076595L (no) Behandling av leversykdommer hvor jern spiller en rolle i patogenesen
CL2011000135A1 (es) Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica.
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
WO2006113631A3 (en) Bioenhanced compositions
PH12012501028A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
WO2009113051A3 (en) Oral modified-release formulations containing thiazepines
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
UY31403A1 (es) "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos".
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
WO2006078659A3 (en) Stable prostaglandin-containing compositions
PA8586301A1 (es) Formulaciones de liberacion prolongada en forma de suspension
WO2007022023A3 (en) Film forming spreading agents
ATE388695T1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
ATE367165T1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
EA201100288A1 (ru) Таблетки телмисартана
UA90742C2 (en) Pyrazolone derivatives
IL195531A0 (en) Oral pharmaceutical composition of a poorly water-soluble active substance
NO20044723L (no) Injiserbare veterinaermedisinske sammensetninger for sma dyr
UA90700C2 (ru) Оральная композиция немедленного выделения на основе слабоводорастворимого действующего вещества
MX2007009142A (es) Formulaciones y regimen de dosificacion para modulares ppar-alfa.
CL2008001411A1 (es) Composicion farmaceutica que comprende al menos una fase interna no lipoidea y al menos una fase externa lipoidea que es bioadhesiva a una superficie de la mucosa vaginal y que comprende danazol de 1 a 30% en peso; procedimiento de preparacion; sistema de administracion; y uso para tratar afecciones inflamatorias

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application